Search
Showing results for "aboriginal respiratory"
Vitamin D may be essential for restricting the development and severity of allergic diseases and asthma, but a direct causal link between vitamin D...
We investigated the suggestion that otitis-prone children have an impaired antibody response in the context of pneumococcal vaccination.
New research links poor language to lack of Vitamin D in womb.
Exposure of skin to UV radiation (UVR) prior to allergen exposure can inhibit inflammatory airways disease in mice by reducing effector CD4+ T cells in both...
Our findings suggest that utilization of IL-7 by cTFH cells affects production of IgG2 antibodies to PPV23 antigens in some HIV patients
Information about cystic fibrosis awareness month and CF research at The Kids
An Australian-first study demonstrating the effectiveness of a new immunisation against respiratory syncytial virus (RSV) for babies found it to be almost 90 per cent effective in reducing hospitalisation rates and helped more than 500 WA families avoid a hospital stay.
A world-first study has found a new vaccine against potentially deadly respiratory syncytial virus (RSV) is safe and effective for use in pregnant women, to help protect their babies.
World-first immunisations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades.
The Kids Research Institute Australia researchers have been awarded 12 grants in the latest round of funding from the WA Child Health Research Fund (formerly the Telethon-Perth Children’s Hospital Research Fund).